Hematology NewsVIDEO: Ibrutinib PFS is nearly 3 years in MCL patients who had one prior therapyDecember 13, 2017Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology NewsVTE rates in lenalidomide-treated NHL may warrant prophylaxisDecember 12, 2017ThrombosisAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsVIDEO: Venetoclax/rituximab prolongs PFS in relapsed/refractory CLLDecember 12, 2017CLLLeukemia, Myelodysplasia, TransplantationAggressive Lymphomas
Hematology NewsVIDEO: CAR T cell axi-cel drives B-cell lymphomas into remissionDecember 11, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersImmuno-oncologyFollicular LymphomaB Cell Lymphoma
Hematology NewsThree-month response to CAR T-cells looks durable in DLBCLDecember 11, 2017Transfusion MedicineAggressive LymphomasImmuno-oncologyLymphoma & Plasma Cell Disorders
Hematology NewsMAVORIC: Mogamulizumab tops vorinostat in pretreated CTCLDecember 10, 2017T Cell LymphomasLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology NewsUpdated ZUMA-1 data show durable CAR-T responses in B-cell lymphomasDecember 10, 2017Aggressive LymphomasCellular TherapyIndolent LymphomaLymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncologyFollicular Lymphoma
Hematology TimesCombo prolongs survival in lymphoma modelsDecember 1, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsASCT or novel therapies in early relapsing follicular lymphoma?November 30, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesInhibitor exhibits activity against range of lymphomasNovember 30, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCCSs have increased risk of hypertensionNovember 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsCAR T-cells gain ground against hematologic cancersNovember 22, 2017Aggressive LymphomasMultiple MyelomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesMethod identifies effective treatments for leukemias, lymphomasNovember 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsCAR T-cell therapy: Moving from cost to valueNovember 21, 2017ALLAggressive LymphomasImmuno-oncology
Hematology TimesFDA expands approval of obinutuzumabNovember 17, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
